03:38:35 EDT Mon 20 Sep 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

BMO appoints Seigerman as director of health care

2021-06-22 11:07 ET - News Release

Mr. Bert Powell reports

BMO CAPITAL MARKETS FOCUSED ON EXPANDING HEALTHCARE FRANCHISE

Bank of Montreal's BMO Capital Markets has hired Evan Seigerman as a managing director and senior equity research analyst covering the biotechnology and pharmaceutical industries.

Mr. Seigerman's hire is a key part of BMO's continuing strategy to build out its health care franchise to meet the needs of clients. BMO continues to deepen its expertise and expand services in health care across the enterprise -- including capital markets, business, and commercial banking and wealth -- where it has deep ties with clients from service providers to biotech innovators and offers dedicated banking services to help health care professionals grow their businesses and manage their finances.

Mr. Seigerman will be based in New York and report to Bert Powell, global director of equity research. He will drive the expansion of BMO's health care research franchise, which currently consists of four analysts -- including Mr. Seigerman -- as well as:

  • Gary Nachman, who covers biopharma/biotechnology;
  • Matthew Luchini, who covers biotechnology;
  • Matt Borsch, CFA, who covers managed care/providers.

"Evan brings a deep understanding of the biotech sector across market caps and therapeutic areas," said Mr. Powell. "In addition, he brings a client-centric focus with the vision to build a market-leading research franchise."

Mr. Seigerman has over a decade of experience, most recently at Credit Suisse in New York where he covered the United States biopharmaceuticals sector. He has worked at Barclays Capital and Deutsche Bank Securities, also in New York, and was selected by Business Insider as a 2021 rising star of equity research.

In addition to Mr. Seigerman, Trung Huynh is joining the BMO health care research team to support the firm's expansion and growth. Mr. Huynh has more than 10 years of experience covering therapeutic and pharmaceutical companies and, most recently, was with Credit Suisse in London. He holds degrees from Imperial College and Loughborough University.

© 2021 Canjex Publishing Ltd. All rights reserved.